NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 11, 2025 $5.69 -2.77% $5.46 V 95.83% 1
Jun 11, 2025 $5.75 -1.73% $5.46 V 94.72% 1
Jun 11, 2025 Bullish $5.46 X 0
Jun 10, 2025 $5.69 -2.83% $5.85 V 97.34% 1
Jun 10, 2025 $5.76 -1.77% $5.85 V 98.40% 1
@.93405
Jun 10, 2025 $6.04 +3.07% $5.85 X 96.75% 0
Jun 10, 2025 Bullish $5.85 X 0
Jun 9, 2025 $5.87 -2.80% $5.86 V 99.82% 6
Jun 9, 2025 $5.93 -1.75% $5.86 V 98.74% 2
Jun 9, 2025 Bullish $5.86 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE